All data are based on the daily closing price as of February 24, 2025
t

Towa Pharmaceutical

4553.TSE
18.79 USD
-0.22
-1.16%

Overview

Last close
18.79 usd
Market cap
924.91M usd
52 week high
21.55 usd
52 week low
15.68 usd
Target price
25.09 usd

Valuation

P/E
7.2151
Forward P/E
16.7785
Price/Sales
0.5491
Price/Book Value
0.8231
Enterprise Value
2.23B usd
EV/Revenue
1.3158
EV/EBITDA
10.9526

Key financials

Revenue TTM
1.70B usd
Gross Profit TTM
613.74M usd
EBITDA TTM
277.63M usd
Earnings per Share
2.62 usd
Dividend
0.4 usd
Total assets
3.08B usd
Net debt
1.25B usd

About

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, development and OEM manufacturing of health food, pharmaceuticals, general food and other products. The company was founded in 1951 and is headquartered in Osaka, Japan.
  • Symbol
    4553.TSE
  • Exchange
    TSE
  • Isin
    JP3623150004
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Osaka
  • Web site
    https://www.towayakuhin.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top